-transparent.png){kind=logo}
A vaccine against Herpes simplex virus infection was prepared by Nonidet NP 40 and formalin treatment of a type 1, infected-cell extract; virus particles were removed by ultracentrifugation over sucrose. These procedures were not detrimental to the antigenic quality of the vaccine preparation. The vaccine afforded significant protection to experimental type 2 genital herpes virus infection in mice, as adjudged by clinical observations, cytopathological change, and virus yields.
Related Publications
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
September 1981,
Research in veterinary science,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
January 1978,
Infection,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
November 1983,
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
July 1978,
Medical microbiology and immunology,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
May 1977,
Infection and immunity,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
January 1982,
Microbiology and immunology,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
January 1997,
The Journal of infectious diseases,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
July 1998,
The Journal of infectious diseases,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
July 1988,
Acta virologica,
G R Skinner, and
D R Williams, and
A Buchan, and
J Whitney, and
M Harding, and
K Bodfish
July 1973,
Zeitschrift fur Hautkrankheiten,
